$SHOP

Cathie Wood’s ARK sells Shopify stock, buys Cerebras Systems

Investing.com reports Cathie Wood’s ARK ETFs published Thursday trades. ARK bought 106,941 shares of Cerebras Systems (CBRS) for about $28.0M and bought Securitize (SECZ) and Perceptive Capital Solutions (FRNM). It sold Shopify (SHOP) 57,045 shares for about $8.6M and sold Palantir (PLTR) for about $7.5M, plus other smaller trades.

Original reporting
Published Aug 14, 2026, 12:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 4:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SHOP
Neutral
medium confidence
Mentioned
$SHOP · $CBRS · $PLTR · $SECZ · $FRNM · $SDGR
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SHOPNeutralLow
01

Why it matters

For traders, the actionable element is the disclosed flow into or out of specific tickers, which can influence short-term sentiment but is not presented as a fundamental catalyst.

02

Market read

This is a fund-flow and sentiment read-through from ARK’s disclosed trades, with mixed direction across the named tickers.

03

What to watch

The article does not state ARK’s total position sizes, cost basis, or whether trades are part of a pre-planned rebalance, limiting inference about conviction.

Relevance 4/10Novelty 3/10Timing: daily ARK trade disclosure for Aug 13, 2026

Background

The piece summarizes ARK ETF daily trades for Aug 13, 2026, highlighting several buys and sells across multiple holdings.

Company-level read

Ticker impact

$SHOPNeutralMedium confidence
Context

ARK sold 57,045 shares of Shopify across ARKK, ARKW, and ARKF, continuing a multi-day position reduction.

Expected impact

Likely limited near-term impact unless follow-on selling accelerates or coincides with other SHOP-specific news.

Evidence & confidence

The article provides only disclosed trade sizes and does not cite new Shopify fundamentals, guidance, or regulatory/product events.

$CBRSBullishMedium confidence
Context

ARK bought 106,941 shares of Cerebras Systems, totaling about $28.0M, split between ARKK and ARKW.

Expected impact

Mild positive bias for sentiment, with follow-through dependent on broader market and CBRS-specific catalysts not mentioned here.

Evidence & confidence

The article is a daily ARK trade disclosure; it does not include new CBRS financial results, contracts, or trial/regulatory milestones.

$PLTRBearishLow confidence
Context

ARK sold 43,874 shares of Palantir for about $7.5M, continuing a pattern of selling over the past few days.

Expected impact

Potential short-term drag if traders interpret it as reduced conviction, but magnitude is unclear versus total fund holdings.

Evidence & confidence

The text shows trade activity only; it does not provide PLTR-specific negative news or a stated rationale.

$SECZBullishLow confidence
Context

ARK acquired 192,702 shares of Securitize through ARKF, totaling about $1.51M.

Expected impact

Limited impact unless the buying is part of a larger, sustained accumulation trend.

Evidence & confidence

The article provides only the disclosed purchase size and no additional SECZ catalyst.

$FRNMBullishLow confidence
Context

ARK increased holdings in Perceptive Capital Solutions by buying 123,842 shares for about $1.43M.

Expected impact

Likely negligible to small near-term effect on price absent other news.

Evidence & confidence

No FRNM-specific developments are described beyond the trade disclosure.

$SDGRBullishLow confidence
Context

ARK bought 28,179 shares of Schrodinger via ARKG for about $0.52M.

Expected impact

Minimal impact expected based solely on this disclosed trade size.

Evidence & confidence

The text does not mention trial results, approvals, or guidance changes for SDGR.

$TXGBearishLow confidence
Context

ARK sold 51,171 shares of 10X Genomics for about $2.96M.

Expected impact

Limited near-term impact unless it reflects a broader de-risking trend.

Evidence & confidence

The article provides trade activity only and no TXG-specific negative event.

Market effects

Flow signals across software/AI (PLTR, CBRS), e-commerce (SHOP), and biotech/life sciences tools (SDGR, TXG) without sector-wide fundamental drivers.

Primarily US-listed names; no cross-region macro or policy linkage beyond a brief market wrap.

No direct global linkage; trades are fund-specific rather than tied to global events.

Counterpoint

ARK trade disclosures can be driven by portfolio rebalancing, liquidity management, or ETF mechanics, so the market may overreact to the headline buys/sells.

Key entities

  • ARK ETFs (ARKK, ARKW, ARKF, ARKG)

    Cathie Wood’s ARK exchange-traded funds that executed the disclosed trades.

  • Shopify Inc.

    ARK reduced its position via a reported sale of shares across multiple ARK ETFs.

  • Cerebras Systems Inc.

    ARK added shares via a reported purchase split between ARKK and ARKW.

  • Palantir Technologies Inc.

    ARK sold shares, continuing a recent selling pattern described in the article.

Related articles

$PLTRHighAI 8/10

Palantir (PLTR) stock forecast: Wall Street see 11% upside after 7% selloff

Palantir (PLTR) shares fell 7.22% to $186.03 on October 16, but analysts see 11% upside with a $206.43 average target. Q2 revenue surged 93% to $1.94B, driven by US commercial growth. Goldman Sachs, Baird, and Mizuho set targets at $230, $250, and $245, respectively, citing AI demand. Valuation concerns remain due to high P/E and revenue multiples.

$PLTRMedAI 8/10

Palantir Stock Fell 7% in a Day and Slipped Into a Correction. Here’s Where It Could Go by 2030

Palantir (PLTR) fell 7.22% to $186.03, entering a correction. The drop was part of a broader software sector decline, with no company-specific news. Customers Bank (CUBI) announced a deal with Palantir for AI deposit onboarding. Palantir reported record deal counts in Q2, with 220 deals worth $1M+ and 73 worth $10M+. U.S. commercial bookings reached $2.132B.

$SHOPMed

Shopify Price Hikes Signal Pricing Power as JPMorgan Keeps $200 Bullish Target - Shopify (NASDAQ:SHOP)

Shopify (NASDAQ:SHOP) raised prices for its Grow and Advanced plans by 13% and 20%, respectively. JPMorgan expects this to generate over $40M in incremental annual revenue, with minimal churn risk. The firm maintains an Overweight rating and $200 price target, citing Shopify's pricing power and AI-related growth. Q3 earnings are expected at 46 cents per share on $3.75B revenue. Shares fell 4.51% to $170.11 on Friday.

$PLTRMed

PLTR Stock Falls Below $190 as AI Financing Risks Trigger Tech Sell-Off

Palantir (PLTR) shares fell 5% on Friday, dropping below $190 after reaching a record high of $213. The decline follows a tech sell-off driven by rising borrowing costs and concerns about debt-financed tech infrastructure. Despite strong Q2 earnings, including $1.94B revenue and $0.41 EPS, Palantir's valuation and market sentiment remain under pressure. Goldman Sachs upgraded PLTR to Buy with a $230 target, but technical and valuation risks persist.

$SHOPMed

RBC raises Shopify price target to $200 on sustained growth outlook

RBC Capital Markets increased its price target for Shopify to $200 from $180, citing strong growth momentum and potential for exceeding market expectations. The bank expects Shopify to sustain growth above 30%, supported by merchant sales, pricing increases, and AI-driven commerce opportunities. Shopify recently expanded access to its product catalogue for AI agents. The company is set to report Q3 results on November 3, with Q2 revenue growth at 34% and Q3 guidance in the low 30% range.